EP4 and EP2 Receptor Activation of Protein Kinase A by Prostaglandin E2 Impairs Macrophage Phagocytosis of Clostridium sordellii

American Journal of Reproductive Immunology

Volumn 71, Issue 1, 2014, Pages 34-43

  Rogers, Lisa M ^a   Thelen, Tennille ^b,c   Fordyce, Krystle ^a   Bourdonnay, Emilie ^a   Lewis, Casey ^a   Yu, Han ^d   Zhang, Junyong ^d   Xie, Jingli ^d   Serezani, Carlos H ^e   Peters Golden, Marc ^a   Aronoff, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d JIAXING UNIVERSITY   (China)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abortion; Endometritis; Innate immunity; Phagocytosis; Pregnancy; Toxic shock syndrome

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; SCAVENGER RECEPTOR; CYCLIC AMP; ISOPROTEIN;

ARTICLE; CELL LINE; CLOSTRIDIUM SORDELLII; HUMAN; HUMAN CELL; IMMUNOREGULATION; INGESTION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; CLOSTRIDIUM INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM;

CELL LINE; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM SORDELLII; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; MACROPHAGES; PHAGOCYTOSIS; PROTEIN ISOFORMS; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 84890132730     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12153     Document Type: Article

References (60)

1. Aldape MJ, Bryant AE, Stevens DL: Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43:1436-1446.
2. Zane S, Guarner J: Gynecologic clostridial toxic shock in women of reproductive age. Curr Infect Dis Rep 2011; 13:561-570.
3. O'Brien DK, Therit BH, Woodman ME, Melville SB: The role of neutrophils and monocytic cells in controlling the initiation of Clostridium perfringens gas gangrene. FEMS Immunol Med Microbiol 2007; 50:86-93.
4. Paredes-Sabja D, Cofre-Araneda G, Brito-Silva C, Pizarro-Guajardo M, Sarker MR: Clostridium difficile spore-macrophage interactions: spore survival. PLoS ONE 2012; 7:e43635.
5. Paredes-Sabja D, Sarker MR: Interactions between Clostridium perfringens spores and Raw 264.7 macrophages. Anaerobe 2012; 18:148-156.
6. Thelen T, Hao Y, Medeiros AI, Curtis JL, Serezani CH, Kobzik L, Harris LH, Aronoff DM: The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J Immunol 2010; 185:4328-4335.
7. Aronoff DM, Hao Y, Chung J, Coleman N, Lewis C, Peres CM, Serezani CH, Chen GH, Flamand N, Brock TG, Peters-Golden M: Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J Immunol 2008; 180:8220-8230.
8. Hertelendy F, Zakar T: Prostaglandins and the myometrium and cervix. Prostaglandins Leukot Essent Fatty Acids 2004; 70:207-222.
9. Olson DM, Ammann C: Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 2007; 12:1329-1343.
10. Koeberle A, Werz O: Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)-a critical review. Curr Med Chem 2009; 16:4274-4296.
11. Fortier MA, Krishnaswamy K, Danyod G, Boucher-Kovalik S, Chapdalaine P: A postgenomic integrated view of prostaglandins in reproduction: implications for other body systems. J Physiol Pharmacol 2008; 59(Suppl 1):65-89.
12. Sugimoto Y, Narumiya S: Prostaglandin E receptors. J Biol Chem 2007; 282:11613-11617.
13. Sreeramkumar V, Fresno M, Cuesta N: Prostaglandin E(2) and T cells: friends or foes? Immunol Cell Biol 2011; 90:579-586.
14. 2. J Immunol 2012; 188:21-28.
15. 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 2004; 173:559-565.
16. 2 overproduction in impaired pulmonary host response following bone marrow transplantation. J Immunol 2006; 177:5499-5508.
17. 2 modulates the severity of infection caused by Streptococcus pyogenes. J Immunol 2010; 185:2372-2381.
18. 2-mediated inhibition of phagocytosis of fungi. Sci Signal 2012; 5:ra12.
19. Hertelendy F, Woods R, Jaffe BM: Prostaglandin E levels in peripheral blood during labor. Prostaglandins 1973; 3:223-227.
20. Kovatz S, Arber I, Korzets Z, Rathaus M, Ben Aderet N, Bernheim J: Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxemia. Nephron 1985; 40:48-51.
21. Lee SE, Romero R, Park IS, Seong HS, Park CW, Yoon BH: Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008; 21:89-94.
22. Xie J, Cao S, Good D, Wei M, Ren X: Combination of a fluorescent dye and a Zn-S cluster and its biological application as a stain for bacteria. Inorg Chem 2010; 49:1319-1321.
23. Wan CP, Park CS, Lau BH: A rapid and simple microfluorometric phagocytosis assay. J Immunol Methods 1993; 162:1-7.
24. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP: Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J 2002; 16:583-585.
25. Benz PM, Feller SM, Sickmann A, Walter U, Renne T: Prostaglandin-induced VASP phosphorylation controls alpha II-spectrin breakdown in apoptotic cells. Int Immunopharmacol 2008; 8:319-324.
26. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
27. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000; 1483:285-293.
28. Katsuyama M, Ikegami R, Karahashi H, Amano F, Sugimoto Y, Ichikawa A: Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochem Biophys Res Commun 1998; 251:727-731.
29. Ikegami R, Sugimoto Y, Segi E, Katsuyama M, Karahashi H, Amano F, Maruyama T, Yamane H, Tsuchiya S, Ichikawa A: The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J Immunol 2001; 166:4689-4696.
30. 2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002; 277:44147-44154.
31. 2 augments IL-10 signaling and function. J Immunol 2006; 177:1092-1100.
32. Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M: Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 2008; 39:127-132.
33. Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS, Zaccolo M: Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 2008; 103:836-844.
34. Kim SH, Serezani CH, Okunishi K, Zaslona Z, Aronoff DM, Peters-Golden M: Distinct protein kinase A anchoring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macrophages. J Biol Chem 2011; 286:8875-8883.
35. WHO: Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and the World Bank (http://www.who.int/whosis/mme_2005.pdf) 2007.
36. Ahman E, Shah IH: New estimates and trends regarding unsafe abortion mortality. Int J Gynaecol Obstet 2011; 115:121-126.
37. Fawcus SR: Maternal mortality and unsafe abortion. Best Pract Res Clin Obstet Gynaecol 2008; 22:533-548.
38. Seale AC, Mwaniki M, Newton CR, Berkley JA: Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 2009; 9:428-438.
39. Mor G, Cardenas I: The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63:425-433.
40. Mason KL, Aronoff DM: Postpartum group A Streptococcus sepsis and maternal immunology. Am J Reprod Immunol 2012; 67:91-100.
41. Deutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C, Schrag S: Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53:114-123.
42. Goulet V, Hebert M, Hedberg C, Laurent E, Vaillant V, De VH, Desenclos JC: Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. Clin Infect Dis 2012; 54:652-660.
43. Sriskandan S: Severe peripartum sepsis. J R Coll Physicians Edinb 2011; 41:339-346.
44. Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL: Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol 2008; 199:332-337.
45. Rouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, Guarner J, Killgore GE, Coffman B, Campbell J, Zaki SR, McDonald LC: Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008; 198:635-e631.
46. Hasegawa M, Kamada N, Jiao Y, Liu MZ, Nunez G, Inohara N: Protective role of commensals AGAINST Clostridium difficile infection via an IL-1beta-mediated positive-feedback loop. J Immunol 2012; 189:3085-3091.
47. Jarchum I, Liu M, Shi C, Equinda M, Pamer EG: Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis. Infect Immun 2012; 80:2989-2996.
48. O'Brien DK, Melville SB: Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 2004; 72:5204-5215.
49. O'Brien DK, Melville SB: Multiple effects on Clostridium perfringens binding, uptake and trafficking to lysosomes by inhibitors of macrophage phagocytosis receptors. Microbiology 2003; 149:1377-1386.
50. Vinals M, Bermudez I, Llaverias G, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC: Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages. Cardiovasc Res 2005; 66:141-149.
51. 2 contributes to the development of endometriosis. Am J Pathol 2010; 176:850-860.
52. Kvirkvelia N, Vojnovic I, Warner TD, Athie-Morales V, Free P, Rayment N, Chain BM, Rademacher TW, Lund T, Roitt IM, Delves PJ: Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin Exp Immunol 2002; 127:263-269.
53. Parhar RS, Kennedy TG, Lala PK: Suppression of lymphocyte alloreactivity by early gestational human decidua I. Characterization of suppressor cells and suppressor molecules. Cell Immunol 1988; 116:392-410.
54. Scodras JM, Parhar RS, Kennedy TG, Lala PK: Prostaglandin-mediated inactivation of natural killer cells in the murine decidua. Cell Immunol 1990; 127:352-367.
55. Tawfik OW, Hunt JS, Wood GW: Implication of prostaglandin E2 in soluble factor-mediated immune suppression by murine decidual cells. Am J Reprod Immunol Microbiol 1986; 12:111-117.
56. 2) and uterine involution in the cow. Theriogenology 1991; 36:1071-1090.
57. Liu W, Dubinett S, Patterson SL, Kelly KA: COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells. Microbes Infect 2006; 8:478-486.
58. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K: Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42:1530-1536.
59. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26:171-176.
60. 4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes. J Immunol 2013; 190:1614-1622.